Corazon (corsee) D. Sanders - 15 Jun 2026 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Reporting relationship
Director
Issuer ticker
RARE
Reported as of
15 Jun 2026
Net transaction value
-$50,100
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jun 2026, 18:50:54 UTC
Prior SEC filing
27 May 2026
Next SEC filing
29 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Karah Parschauer, attorney-in-fact

Key filing fact

Corazon (corsee) D. Sanders filed Form 4 for Ultragenyx Pharmaceutical Inc. (RARE) on 15 Jun 2026.

Key facts

  • This page summarizes Corazon (corsee) D. Sanders's Form 4 filing for Ultragenyx Pharmaceutical Inc. (RARE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Jun 2026, 18:50.

Change

  • Previous filing in this sequence was filed on 27 May 2026.
  • Current net transaction value: -$50,100.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001796536 Primary reporting owner

Sanders Corazon (Corsee) D.

Relationship
Director
Address
C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO
Signature
/s/ Karah Parschauer, attorney-in-fact
Signature date
15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RARE transaction

Common Stock

Sale

Transaction value
$50,100
Shares
-2,000
Change %
-8.7%
Price
$25.05
Shares after
21,095
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .